CN Stock MarketDetailed Quotes
688180 Shanghai Junshi Biosciences Co., Ltd.
- 27.72
- +1.57+6.00%
Market Closed Sep 27 15:00 CST
27.32BMarket Cap-14150P/E (TTM)
28.18High26.25Low67.06KlotVolume26.74Open26.15Pre Close180.98MTurnover0.88%Turnover RatioLossP/E (Static)985.69MShares49.4352wk High4.22P/B21.19BFloat Cap23.0852wk Low31.38Limit Up764.55MShs Float220.40Historical High20.92Limit Down7.38%Amplitude23.08Historical Low--Dividend TTM26.99Avg Price30.59KlotAsk--Div YieldTTM100Lot Size31.80KlotBid
Shanghai Junshi Biosciences Co., Ltd. Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 70.21%840.72M | 71.52%396.31M | -38.45%1.47B | -52.84%994.9M | -74.09%493.94M | -84.28%231.06M | -28.20%2.4B | -18.39%2.11B | -18.81%1.91B | -0.08%1.47B |
| Refunds of taxes and levies | -91.88%10.55M | ---- | -52.03%143.93M | -50.57%143.93M | -45.02%129.85M | ---- | 314.60%300.01M | 302.41%291.2M | 226.37%236.17M | 19.12%71.41M |
| Cash received relating to other operating activities | -84.21%15.87M | -95.74%3.02M | 182.35%122.67M | 240.33%97.65M | 804.11%100.46M | 2,163.08%70.94M | -67.60%43.45M | -52.71%28.69M | -80.50%11.11M | -92.57%3.13M |
| Cash inflows from operating activities | 19.73%867.13M | 32.23%399.33M | -36.43%1.74B | -49.10%1.24B | -66.37%724.25M | -80.44%302M | -22.69%2.74B | -10.61%2.43B | -13.06%2.15B | -1.83%1.54B |
| Goods services cash paid | -18.89%883.18M | -22.90%433.71M | -30.16%2.08B | -30.75%1.65B | -39.74%1.09B | 9.68%562.54M | 9.23%2.98B | 5.11%2.38B | 5.37%1.81B | -30.80%512.87M |
| Staff behalf paid | 1.27%666.06M | -21.45%289.14M | -1.26%1.25B | -4.62%958.34M | -3.72%657.74M | -7.56%368.1M | 13.73%1.27B | 19.03%1B | 12.61%683.12M | 11.98%398.21M |
| All taxes paid | 6.22%43.73M | -3.27%23.37M | 104.23%78.51M | 158.48%58.01M | 182.48%41.17M | 358.80%24.16M | 31.77%38.44M | -0.59%22.44M | -8.64%14.57M | -6.15%5.27M |
| Cash paid relating to other operating activities | -13.96%139.5M | -55.98%29.7M | 47.28%330.45M | 70.00%235.33M | 51.64%162.13M | 17.80%67.46M | -17.51%224.37M | 9.99%138.43M | 13.96%106.92M | -19.10%57.27M |
| Cash outflows from operating activities | -11.15%1.73B | -24.10%775.91M | -17.04%3.75B | -18.22%2.9B | -25.34%1.95B | 5.00%1.02B | 8.85%4.52B | 8.87%3.55B | 7.41%2.61B | -17.01%973.61M |
| Net cash flows from operating activities | 29.40%-865.35M | 47.72%-376.58M | -12.88%-2B | -48.92%-1.66B | -167.49%-1.23B | -226.26%-720.25M | -193.56%-1.78B | -106.90%-1.12B | -1,104.52%-458.23M | 42.75%570.43M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -79.22%250M | -62.77%150M | 1,270.19%1.25B | 1,224.63%1.21B | 1,221.82%1.2B | --402.85M | -83.87%91M | -70.06%91M | -70.06%91M | ---- |
| Cash received from returns on investments | -90.81%389.04K | ---- | 1,631.72%4.23M | 1,631.72%4.23M | 1,631.72%4.23M | --1.77M | -80.84%244.53K | -68.88%244.53K | -68.88%244.53K | ---- |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 8,329.81%1.87M | ---- | 620,682.93%4.1M | 3,252.10%22.12K | 3,252.10%22.12K | ---- | -94.29%660 | -24.40%660 | -24.40%660 | ---- |
| Cash received relating to other investing activities | -57.05%24.98M | -49.97%14.08M | 69.22%103.19M | 93.06%81.17M | 120.08%58.17M | 175.04%28.15M | 96.84%60.98M | 68.23%42.04M | 40.72%26.43M | -0.30%10.23M |
| Cash inflows from investing activities | -78.09%277.24M | -62.09%164.08M | 792.37%1.36B | 868.45%1.29B | 975.22%1.27B | 4,128.57%432.77M | -74.47%152.22M | -59.58%133.29M | -63.63%117.68M | -0.30%10.23M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 96.45%395.71M | 68.97%212.29M | 111.34%832.57M | 112.80%604.66M | 32.99%201.43M | 29.43%125.64M | -56.31%393.95M | -56.99%284.14M | -69.67%151.46M | -57.04%97.07M |
| Cash paid to acquire investments | -32.52%830M | -96.87%25.06M | 646.36%1.46B | 585.48%1.34B | 529.21%1.23B | 804.12%800M | -87.86%195.48M | -82.31%195.48M | -80.32%195.48M | -67.55%88.48M |
| Cash outflows from investing activities | -14.37%1.23B | -74.36%237.35M | 288.78%2.29B | 305.46%1.94B | 312.58%1.43B | 398.85%925.64M | -76.55%589.44M | -73.14%479.62M | -76.79%346.94M | -62.87%185.56M |
| Net cash flows from investing activities | -470.85%-948.48M | 85.13%-73.27M | -113.44%-933.19M | -88.79%-653.83M | 27.53%-166.15M | -181.13%-492.87M | 77.20%-437.21M | 76.22%-346.34M | 80.43%-229.27M | 64.19%-175.32M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | -96.28%155.59M | -60.81%155.59M | -60.81%155.59M | -59.05%155.59M | 38.47%4.18B | -81.29%396.98M | -81.29%396.98M | --380M |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | -99.22%3M | -99.21%3M | -99.21%3M | -99.21%3M | -56.87%386M | --380M | --380M | --380M |
| Cash from borrowing | 568.08%1.43B | 1,299.67%1.28B | 16.27%977.1M | -21.55%602.68M | -48.89%214.73M | --91.3M | 68.07%840.36M | 53.64%768.21M | --420.11M | ---- |
| Cash received relating to other financing activities | -90.98%3.73M | -46.05%902.53K | 3,038.00%207.89M | 13,696.62%179.51M | 3,074.13%41.3M | --1.67M | --6.62M | --1.3M | --1.3M | ---- |
| Cash inflows from financing activities | 249.42%1.44B | 414.47%1.28B | -73.32%1.34B | -19.61%937.79M | -49.70%411.62M | -34.59%248.57M | 42.87%5.02B | -55.51%1.17B | -61.43%818.39M | --380M |
| Borrowing repayment | 443.44%634.03M | 100.00%30M | 323.92%480.92M | 3,792.29%389.23M | 2,233.38%116.67M | 200.00%15M | -85.70%113.45M | -98.74%10M | -90.62%5M | --5M |
| Dividend interest payment | 88.14%33.86M | 55.26%13.64M | 99.54%38.23M | 63.18%27.7M | 81.72%18M | 81.44%8.79M | 14.78%19.16M | -38.53%16.97M | -51.09%9.9M | -52.06%4.84M |
| Cash payments relating to other financing activities | -47.53%28M | 15.01%15.33M | -60.60%109.61M | -72.15%79.67M | -80.13%53.36M | 2.78%13.33M | 578.15%278.2M | 829.68%286.11M | 1,242.24%268.57M | 48.42%12.97M |
| Cash outflows from financing activities | 270.11%695.89M | 58.89%58.97M | 53.05%628.75M | 58.62%496.6M | -33.67%188.02M | 62.71%37.11M | -51.73%410.81M | -63.24%313.08M | 202.88%283.47M | 21.08%22.81M |
| Net cash flows from financing activities | 232.02%742.38M | 476.88%1.22B | -84.57%711.83M | -48.30%441.19M | -58.20%223.6M | -40.80%211.45M | 73.07%4.61B | -51.79%853.4M | -73.63%534.92M | 1,996.00%357.19M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -80.99%4.77M | 111.75%1.25M | -91.82%7.55M | -79.92%21.54M | -54.39%25.1M | -834.70%-10.64M | 497.25%92.27M | 1,055.69%107.23M | 395.97%55.03M | -76.10%1.45M |
| Net increase in cash and cash equivalents | 6.69%-1.07B | 176.19%771.24M | -189.02%-2.22B | -268.69%-1.86B | -1,071.94%-1.14B | -234.30%-1.01B | 1,983.76%2.49B | -111.84%-503.19M | -111.04%-97.55M | 833.85%753.75M |
| Add:Begin period cash and cash equivalents | -37.00%3.78B | -37.00%3.78B | 71.12%6B | 71.12%6B | 71.12%6B | 71.12%6B | 3.53%3.5B | 3.53%3.5B | 3.53%3.5B | 3.53%3.5B |
| End period cash equivalent | -44.14%2.71B | -8.73%4.55B | -37.00%3.78B | 37.99%4.14B | 42.46%4.85B | 17.06%4.98B | 71.12%6B | -4.64%3B | -20.18%3.41B | 29.74%4.26B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- |
| Auditor | -- | -- | Rong Shing Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Shing Certified Public Accountants (Special General Partnership) | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data